role of ponatinib in treatment of r/r cml
Published 5 years ago • 100 plays • Length 5:03Download video MP4
Download video MP3
Similar videos
-
5:22
bosutinib versus ponatinib in r/r cml
-
5:27
early intervention with ponatinib in treatment of cml
-
3:20
case 1: ponatinib in chronic-phase cml
-
24:30
management of thrombosis risk with ponatinib and other tkis for cml?
-
5:07
case 2: ponatinib for t315i-mutated cml
-
1:17
ponatinib versus ascimininib in the third-line treatment of cml
-
2:49
outcomes of patients with cml-cp treated with ponatinib vs 2g-tkis in the third-line setting
-
1:35
safety of ponatinib in chronic-phase chronic myeloid leukemia (cml) patients
-
1:37
optic: ponatinib in chronic-phase cml
-
1:56
dr. cortes on ponatinib in patients with cml and ph all
-
2:50
ponatinib and its role in treating all
-
1:38
an update on the optic study: adjusting the dose of ponatinib for cp-cml
-
7:39
upfront treatment in chronic myeloid leukemia (cml)
-
1:12
dr. cortes discusses the use of ponatinib in types of leukemia
-
3:31
ash 2021: new optic trial analysis shows ponatinib is effective in chronic myeloid leukemia patients
-
4:12
rationale for tki therapy in relapsed cml
-
2:25
dose reduction and third-line therapy for cml
-
4:44
ponatinib in chronic-phase cml patients with prior second generation tki exposure
-
30:14
when can tkis be stopped in cml?